SYNERGY BETWEEN THE INOSITOL PHOSPHATE RESPONSES TO TRANSFECTED HUMAN ADENOSINE A(1)-RECEPTORS AND CONSTITUTIVE P-2-PURINOCEPTORS IN CHO-K1 CELLS

被引:50
|
作者
MEGSON, AC
DICKENSON, JM
TOWNSENDNICHOLSON, A
HILL, SJ
机构
[1] QUEENS MED CTR,SCH MED,DEPT PHYSIOL & PHARMACOL,NOTTINGHAM NG7 2UH,ENGLAND
[2] ST VINCENTS HOSP,GARVAN INST MED RES,SYDNEY,NSW 2010,AUSTRALIA
基金
英国惠康基金;
关键词
A(1)-ADENOSINE RECEPTOR; P-2U-PURINOCEPTOR; NUCLEOTIDE RECEPTOR; INOSITOL PHOSPHATES; CHO-K1; CELLS; SYNERGY;
D O I
10.1111/j.1476-5381.1995.tb16632.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 The effect of adenosine A(1)-receptor and P-2-purinoceptor agonists on [H-3]-inositol phosphate accumulation has been investigated in CHO-K1 cells transfected with the human adenosine A(1)-receptor. 2 Adenosine receptor agonists stimulated [H-3]-inositol phosphate accumulation in CHO-K1 cells with a rank potency order of N-6-cyclopentyladenosine (CPA) > 5'-N-ethylcarboxamidoadenosine (NECA) > 2-chloroadenosine > N-6-2-(4-aminophenyl) ethyladenosine (APNEA). The responses to both CPA and APNEA were antagonized by the A(1) selective antagonist, 1,3-dipropylcyclopentylxanthine (DPCPX) yielding K-D values of 1.2 nM and 4.3 nM respectively. 3 ATP, UTP and ATP gamma S were also able to stimulate [H-3]-inositol phosphate accumulation in these cells with EC(50) values of 1.9 mu M, 1.3 mu M and 5.0 mu M respectively. 2-Methyl-thio-ATP was a weak agonist of this response (EC(50) > 100 mu M). 4 The [H-3]-inositol phosphate response to CPA was completely attenuated by pertussis toxin treatment (24 h; 100 ng ml(-1)). In contrast, the responses to ATP, UTP and ATP gamma S were only reduced by circa 30% in pertussis toxin-treated cells. 5 The simultaneous addition of CPA and either ATP, UTP or ATP gamma S produced a large augmentation of [H-3]-inositol phospholipid hydrolysis. This was due to an increase in the maximal response and was significantly greater than the predicted additive response for activation of these two receptor systems. The synergy was not observed in pertussis toxin-treated cells. 6 No synergy was observed between the [H-3]-inositol phosphate responses to histamine and ATP in CHO-K1 cells transfected with the bovine histamine H-1-receptor. In these cells the response to histamine was completely resistant to inhibition by pertussis toxin treatment. 7 This study provides a clear demonstration of a synergy between pertussis toxin-sensitive and insensitive receptor systems in a model cell system which is an ideal host for transfected cDNA sequences. This model system should provide a unique opportunity to unravel the mechanisms underlying this example of receptor cross-talk involving phospholipase C.
引用
收藏
页码:1415 / 1424
页数:10
相关论文
共 50 条
  • [31] Agonist-specific temporal characteristics of β2-adrenoceptor-stimulated gene transcription response in CHO-K1 cells transfected with the human β2-adrenoceptor
    Baker, JG
    Hall, IP
    Hill, SJ
    BRITISH JOURNAL OF PHARMACOLOGY, 2002, 135
  • [32] INCREASES IN INTRACELLULAR CALCIUM VIA ACTIVATION OF AN ENDOGENOUS P(2)-PURINOCEPTOR IN CULTURED CHO-K1 CELLS
    IREDALE, PA
    HILL, SJ
    BRITISH JOURNAL OF PHARMACOLOGY, 1993, 110 (04) : 1305 - 1310
  • [33] Heterologous, PKC-Mediated Desensitization of Human Histamine H3 Receptors Expressed in CHO-K1 Cells
    Montejo-Lopez, Wilber
    Rivera-Ramirez, Nayeli
    Escamilla-Sanchez, Juan
    Garcia-Hernandez, Ubaldo
    Arias-Montano, Jose-Antonio
    NEUROCHEMICAL RESEARCH, 2016, 41 (09) : 2415 - 2424
  • [34] Selective somatostatin (SRIF)-induced desensitisation of human recombinant sst4 receptors expressed in CHO-K1 cells
    Smalley, KSM
    Feniuk, W
    Humphrey, PPA
    BRITISH JOURNAL OF PHARMACOLOGY, 1998, 123 : U97 - U97
  • [35] Heterologous, PKC-Mediated Desensitization of Human Histamine H3 Receptors Expressed in CHO-K1 Cells
    Wilber Montejo-López
    Nayeli Rivera-Ramírez
    Juan Escamilla-Sánchez
    Ubaldo García-Hernández
    José-Antonio Arias-Montaño
    Neurochemical Research, 2016, 41 : 2415 - 2424
  • [36] Identification and characterization of an endogenous P2X7 (P2Z) receptor in CHO-K1 cells
    Michel, AD
    Chessell, IP
    Hibell, AD
    Simon, J
    Humphrey, PPA
    BRITISH JOURNAL OF PHARMACOLOGY, 1998, 125 (06) : 1194 - 1201
  • [37] BIBP3226 increases inositol phosphate accumulation and cytosolic calcium level in control and NPY Y1 receptor expressing CHO-K1 cells.
    Vanderheyden, PML
    Van Liefde, I
    DeBacker, JP
    Fierens, F
    Vauquelin, G
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R707 - R707
  • [38] Human 5-HT1B receptor stimulated inositol phospholipid hydrolysis in CHO cells:: synergy with Gq-coupled receptors
    Dickenson, JM
    Hill, SJ
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 348 (2-3) : 279 - 285
  • [39] Comparative pharmacology of recombinant human M3 and M5 muscarinic receptors expressed in CHO-K1 cells
    Watson, N
    Daniels, DV
    Ford, APDW
    Eglen, RM
    Hegde, SS
    BRITISH JOURNAL OF PHARMACOLOGY, 1999, 127 (02) : 590 - 596
  • [40] Procorticotrophin releasing hormone is endoproteolytically processed by the prohormone convertase PC2 but not by PC1 within stably transfected CHO-K1 cells.
    Perone, MJ
    Ahmed, I
    Linton, EA
    Castro, MG
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1996, 24 (03) : S497 - S497